JP Morgan Maintains Underweight on QuidelOrtho, Raises Price Target to $12
JP Morgan analyst Casey Woodring maintains QuidelOrtho (NASDAQ: QDEL ) with a Underweight and raises the price target from $11 to $12.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.